ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY)

CUSIP: 682310875

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock, no par value
Shares outstanding
109,272,143
Total 13F shares
1,364,360
Share change
+57,268
Total reported value
$748,757
Price per share
$0.55
Number of holders
50
Value change
-$5,861
Number of buys
22
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 682310875?
CUSIP 682310875 identifies ONCY - ONCOLYTICS BIOTECH INC - Common Stock, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) as of Q1 2025

As of 31 Mar 2025, ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) was held by 50 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,364,360 shares. The largest 10 holders included INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC, SEEDS INVESTOR LLC, GOLDMAN SACHS GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, ROYAL BANK OF CANADA, FRANKLIN RESOURCES INC, COMMONWEALTH EQUITY SERVICES, LLC, CIBC WORLD MARKET INC., Badgley Phelps Wealth Managers, LLC, and BANK OF MONTREAL /CAN/. This page lists 50 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.